Business - April 10, 2023
The President of Estonia has visited Lund, including MAX IV and ESS
Visiting some of the world’s foremost laboratories in the Swedish city of Lund, President Alar Karis remarked that contributing to their development significantly broadens the horizons of Estonian science, deepens cooperation between researchers and makes new study methods available to them. “Many of the methods used in contemporary science only become available when countries jointly […]
Biotech Business - March 28, 2023
Salipro publishes results from collaboration with AstraZeneca
The study describes a novel method to directly extract membrane proteins from cells into lipid Salipro nanoparticles, enabling structure-function analysis using surface plasmon resonance (SPR) and cryo-electron microscopy (cryo-EM) for challenging drug targets. For this study, the teams leveraged GeneArt Gene-to-Protein Services, part of Thermo Fisher Scientific, for protein production with structure determination support from […]
Agreement - March 27, 2023
Orion and Bayer expand clinical development program
Orion and Bayer further expand the global clinical development program for the oral androgen receptor inhibitor (ARi) darolutamide in prostate cancer. The new Phase III clinical study, ARASTEP, will investigate the efficacy of darolutamide plus androgen deprivation therapy (ADT) versus ADT alone in hormone-sensitive prostate cancer, in patients with high-risk biochemical recurrence (BCR) who have […]
Collaboration - March 22, 2023
The state of Danish research examined in a new report
In the report “The scientific impact of Danish research 1980-2020,” the researchers behind the study state that the scientific impact of Danish research has been on the decline for a number of years. The report was commissioned and funded by the Novo Nordisk Foundation and VILLUM FONDEN and is an update of the report “Fostering […]
Collaboration - March 15, 2023
A leading Norwegian oncology arena
Cancer Crosslinks 2023 was a day of inspiration, insights, and interactions for professionals from across the cancer field in Norway and beyond. The 15th Cancer Crosslinks was held in Oslo Cancer Cluster Innovation Park on 26 January 2023, gathering the oncology community for a day of engaging talks from renowned international and Norwegian experts. The […]
Careers - March 13, 2023
Q&A: Jessica Martinsson, Director General, SwedenBIO
Jessica Martinsson took up her new role as Director General of SwedenBIO on March 1st 2023. NLS asked Jessica about her previous experiences from the life science industry and about current challenges and opportunities for Swedish life science companies. You are the co-founder of, and you have been both operational manager and CEO of Sprint […]
